Ignite Creation Date:
2024-05-06 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05127967
Status:
COMPLETED
Last Update Posted:
2023-02-17
First Post:
2021-10-14
Brief Title:
Consequences of Mutations in the SPG7 Gene at the Heterozygous State
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Phenotypic Biological and Functional Consequences of Mutations in the SPG7 Gene at the Heterozygous State
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CONSP-HET7
Brief Summary:
Paraplegin encoded by the SPG7 gene is an ATP-dependent mAAA protease located in the inner mitochondrial membrane Its function is not fully understood Mutations in the SPG7 gene are responsible for spastic paraplegia type 7 Although spastic paraplegia type 7 is considered to be a recessive disease some clinical observations also point to a detrimental effect of a variant in SPG7 in the heterozygous state Thus the presence of a single mutated variant of the SPG7 gene could be a risk factor for the development of neurological diseases This has important implications for genetic counseling of patients and for the understanding of the function of the SPG7 protein and the mechanisms of disease development
Detailed Description:
Although spastic paraplegia type 7 is considered to be a recessive disease some clinical observations also argue for a detrimental effect of a variant in SPG7 in the heterozygous state Thus the presence of a single mutated variant of the SPG7 gene could be a risk factor for the development of neurological diseases This has important implications for genetic counseling of patients and for the understanding of the function of the SPG7 protein and the mechanisms of disease development To date there have been no studies to specifically explore the pathogenic role of single heterozygous variants in the SPG7 gene
The aim of this project is to fully characterize different models expressing single heterozygous SPG7 mutations in order to detect phenotypical biological or functional alterations In particular the investigators will conduct analysis on fibroblasts from symptomatic patients with mutations in the SPG7 gene homozygous compound heterozygous or single heterozygous and controls Cellular models will be particularly useful in order to study an alteration in calcium homeostasis and in the response to ER stressors In parallel studies will be performed using the genetic animal model of Drosophila melanogaster
The aim of this project is to fully characterize different models expressing single heterozygous SPG7 mutations in order to detect phenotypical biological or functional alterations In particular the investigators will conduct analysis on fibroblasts from symptomatic patients with mutations in the SPG7 gene homozygous compound heterozygous or single heterozygous and controls Cellular models will be particularly useful in order to study an alteration in calcium homeostasis and in the response to ER stressors In parallel studies will be performed using the genetic animal model of Drosophila melanogaster
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None